Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EBS · against 1,216 other Healthcare companies
Ranked #1,163 of 1,217 · scores higher than 4% of peers
Bars: peers in each 10-point band of the growth score116 peers with a growth score of 0–9, including EBS · Click a bar to see the companies
Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | EBS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -30.4% | 6.1% | 7% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -13.1% | 5.8% | 9% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,163 | 31.0B CNY (≈$4.3B) | 4 | 26 | |
| 1,163 | 1.9B CNY (≈$270M) | 4 | 44 | |
| 1,163 | 12.8B CNY (≈$1.8B) | 4 | 44 | |
| 1,163 | 6.0B CNY (≈$841M) | 4 | 29 | |
| 1,163 | 320M USD | 4 | 44 | |
| 1,163 | 24M SEK (≈$2M) | 4 | 14 | |
| 1,163 | 7.8B USD | 4 | 30 | |
| 1,163 | 223M USD | 4 | 34 | |
| 1,163 | 184M USD | 4 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score